Current role
Aaron Deykin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Aaron Deykin
The proxy statement of Upstream Bio, Inc. reports total compensation of $1,830,916 for Aaron Deykin in fiscal 2025, including a base salary of $515,000.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Upstream Bio, Inc. (UPB)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Upstream Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- E. Rand Sutherland CEO
- Samantha Truex CEO
- Allison Ambrose General Counsel
- H. Edward Fleming Board Member
- Liam Ratcliffe Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Upstream Bio, Inc. (UPB) | Chief Medical Officer and Head of Research and Development | $515,000 | $1,830,916 |
Recent activity
No call appearances or filed executive changes recorded yet.